Imeik Technology Development Co.,Ltd.
300896
Classificação em ações
#3842
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Preço da ação
$14.33
Valor de mercado
$4.34B
Variação (1 dia)
3.76%
Variação (1 ano)
-38.92%
País
CN
Negociar Imeik Technology Development Co.,Ltd. (300896)
Categoria
Healthcare
EPS de Imeik Technology Development Co.,Ltd. (300896)
EPS em June 2026 TTM: $0.53
De acordo com os últimos relatórios financeiros e o preço das ações da Imeik Technology Development Co.,Ltd., o EPS atual da empresa (TTM) é $0.53. No final de 2023, a empresa teve um EPS de $0.87, um aumento em relação a ao EPS de 2022, que foi de $0.60.
Histórico de EPS da Imeik Technology Development Co.,Ltd. de 2014 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $0.53 | -40.73% |
| 2024 | $0.89 | 2.66% |
| 2023 | $0.87 | 43.49% |
| 2022 | $0.60 | 21.58% |
| 2021 | $0.50 | 60.03% |
| 2020 | $0.31 | 60.24% |
| 2019 | $0.19 | 75.48% |
| 2018 | $0.11 | 40.94% |
| 2017 | $0.08 | 60.00% |
| 2016 | $0.05 | 189.94% |
| 2015 | $0.02 | -41.92% |
| 2014 | $0.03 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $8.85 | 1,577.73% |
US
|
|
| $6.41 | 1,114.26% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 529.38% |
US
|
|
| - | - |
CH
|
